IMAC Holdings (BACK) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

BACK IMAC Holdings

Watchlist

1.2250
+0.1050+9.38%

Close Oct 16 16:00 ET

1.1800
-0.0450-3.67%

Post 20:01 ET

2.11MMarket Cap-224P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

IMAC Holdings Welcomes Jeffrey Busch to Strengthen Board
TipRanksSep 25 16:29 ET
IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology
GlobeNewswireSep 19 10:00 ET
Imac Holdings Enhances Compensation and Affirms Governance
TipRanksAug 30 16:30 ET
Reported Friday, IMAC Holdings Receives Nasdaq Deficiency Notice Due To Delayed Filing Of Quarterly Report, Commits To Regaining Compliance
BenzingaAug 26 02:45 ET
Imac Holdings Faces Compliance Challenge and Delisting Risk
TipRanksAug 23 17:47 ET
Express News | iMac Holdings Receives Notification of Deficiency From Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
ReutersAug 23 17:20 ET

Comments

Jaguar8

Sep 19 09:01

NEWS

$IMAC Holdings (BACK.US)$
IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology
IMAC Holdings Inc. (Nasdaq: BACK) has launched a new subsidiary, Ignite Proteomics , introducing a groundbreaking precision oncology assay for breast cancer treatment using Reverse Phase Protein Array (RPPA) technology. This follows IMAC's acquisition of key assets from Theralink Technologies, Inc. A landmark clinical case stud...